UCREST
00050.070 ↑
| High | 0.070 |
| Low | 0.065 |
| Open | 0.065 |
| Volume | 4,821,700 |
| Volume (B/S) | 10,000 / 2,900,800 |
| Price Bid/Ask | 0.065 / 0.070 |
| 52w | 0.060 - 0.110 |
| ROE | 11.17 |
| P/E | 10.42 |
| EPS | 0.67 |
| DPS | |
| DY | 0.00% |
| NTA | 0.0600 |
| P/B | 1.17 |
| RPS | 2.32 |
| PSR | 3.01 |
| Market Cap | 52.1M |
| Shares (mil) | 743.83 |
| YoY |
| CAGR |
3Y
29%
TTM
28.9%
5Y
18.9%
TTM
20.8%
|
|
| RSI(14) | Neutral 57.2 |
| Stochastic(14) | Overbought 100.0 |
| Stochastic RSI(14) | Neutral 30.2 |
| Average Volume (3M) | 5,602,200 |
| Relative Volume | 1.0 |
| Financial Year | Revenue ('000) | Net ('000) | EPS | DP% | Net % | Report |
|---|---|---|---|---|---|---|
| 31 May, 2026 | 6,099 | 1,681 | 0.2300 | - | ||
| 31 May, 2025 | 18,440 | 5,167 | 0.6900 | - | 4.9% | View |
| 31 May, 2024 | 16,489 | 4,926 | 0.6700 | - | 4,729.4% | View |
| 31 May, 2023 | 13,610 | 102 | -0.0600 | - | 100.3% | View |
| 31 May, 2022 | 12,227 | -35,101 | -5.6300 | - | 410.2% | View |
| 31 May, 2021 | 25,103 | 11,317 | 2.0100 | - | 182.8% | View |
| 31 May, 2020 | 12,302 | -13,669 | -2.9500 | - | 274.4% | View |
| 31 May, 2019 | 28,878 | 7,839 | 1.6900 | - | 44.7% | View |
| 31 May, 2018 | 48,263 | 14,182 | 3.9400 | - | 1,868.3% | View |
| 31 May, 2017 | 5,714 | -802 | -0.2500 | - | 165.6% | View |
| 31 May, 2016 | 3,154 | -302 | -0.1000 | - | 112.4% | View |
| 31 Dec, 2015 | 468 | 2,426 | 0.8300 | - | ||
| 31 Dec, 2014 | 1,293 | -5,488 | -1.8900 | - | 0.4% | View |
| 31 Dec, 2013 | 3,629 | -5,464 | -1.8800 | - | 952.8% | View |
| 31 Dec, 2012 | 4,099 | -519 | -0.1800 | - | 86.3% | View |
| 31 Dec, 2011 | 6,290 | -3,799 | -1.3100 | - | 22.6% | View |
| 31 Dec, 2010 | 2,432 | -3,098 | -1.0800 | - | 323.8% | View |
| 31 Dec, 2009 | 3,550 | -731 | -0.2500 | - | 85.4% | View |
| 31 Dec, 2008 | 3,694 | -5,024 | -1.7300 | - | 1,263.0% | View |
| 31 Dec, 2007 | 7,634 | 432 | 0.5900 | - | 77.3% | View |
| 31 Dec, 2006 | 17,900 | 1,905 | 1.8000 | - | 169.1% | View |
| 31 Dec, 2005 | 5,006 | -2,757 | -2.6100 | - | 195.2% | View |
| 31 Dec, 2004 | 15,374 | 2,897 | 2.7400 | - | 171.8% | View |
| 31 Dec, 2003 | 27,606 | -4,035 | -4.2000 | - | 1,122.7% | View |
| 31 Dec, 2002 | 3,390 | -330 | -0.3400 | - | View |
| Announced | Financial Year | Subject | EX Date | Payment Date | Amount | Indicator |
|---|
No dividends
| Announced | EX Date | Subject | Ratio | Offer | |
|---|---|---|---|---|---|
| 13 Feb 2013 | 25 Feb 2013 | Rights Issue (warrant) | 1 : 2 | View |
| Name | Price | Change | Volume | Gearing | Premium | Premium % | Maturity |
|---|
No warrants found.
Recent News
-
联峰:iMedic™升级为数字医疗市场平台
(吉隆坡20日讯)联峰(UCREST,0005,创业板科技组)宣布推出人工智能健康(AI Health)驱动的电子商务系统整合进iMedic™数字健康平台,使得iMedic™成为全球首个将病患问诊、处方开具,以及AI Health推荐的个性化药品与保健品整合于远程医疗系统。随着此项升级,iMedic™从数字化医疗管理系统,全面升级为数字医疗市场平台。根据文告,病患可在线咨询医生,在获得处方后,直接于iMedic™平台内购买药品,以及由医生推荐的保健品。所有订单将直接配送至病患手中,打造真正端...Sinchew -
Trading ideas: Kerjaya Prospek, IJM, Zetrix, UCrest, Privasia, Cahya Mata, AIM, United Plantations, Swift, VSTECS, New Hoong Fatt, Synergy
KUALA LUMPUR: Here is a recap of the announcements that made headlines in Corporate Malaysia.TheStar -
UCrest says shares undervalued as AI-powered healthcare business expands
KUALA LUMPUR: UCrest Bhd believes its shares have yet to reflect the company's true value, as rising earnings and advances in artificial intelligence (AI) healthcare set the stage for stronger growth.NST -
UCrest receives patent in Taiwan
UCrest Bhd has been granted its first patent in Taiwan for its flagship product, an artificial intelligence (AI)-powered digital health platform, iMedic.TheStar -
UCrest receives patent in Taiwan
PETALING JAYA: UCrest Bhd has been granted its first patent in Taiwan for its flagship product, an (AI)-powered digital health platform, iMedic™.TheStar
Recent Announcements
-
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING
UCREST BERHAD ("UCREST" OR "COMPANY") PRIVATE PLACEMENT -
OTHERS
UCREST BERHAD ("UCREST" OR "COMPANY") PRIVATE PLACEMENT -
OTHERS
NEWS RELEASE - UCREST BERHAD INTRODUCES iMEDIC LONGEVITY, EXPANDING ITS DIGITAL HEALTH PLATFORM WITH NEW CAPABILITIES FOR FUNCTIONAL AND LONGEVITY MEDICINE -
OTHERS
UCREST BERHAD - ESTABLISHMENT OF EMPLOYEES' SHARE OPTION SCHEME COMMITTEE -
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : ESOS
UCREST BERHAD ("UCREST" OR "COMPANY") ESTABLISHMENT OF AN EMPLOYEES' SHARE OPTION SCHEME ("ESOS") OF UP TO 30% OF THE TOTAL NUMBER OF ISSUED SHARES IN UCREST (EXCLUDING TREASURY SHARES, IF ANY) AT ANY ONE TIME DURING THE DURATION OF THE ESOS FOR THE ELIGIBLE DIRECTORS AND EMPLOYEES OF UCREST AND ITS SUBSIDIARIES (EXCLUDING DORMANT SUBSIDIARIES, IF ANY)